摘要
目的观察丁苯酞软胶囊联合依达拉奉治疗脑梗塞的临床效果。方法选取110例脑梗塞患者,将其随机分为对照组和治疗组,每组各55例。对照组采用依达拉奉治疗,治疗组采用丁苯酞软胶囊联合依达拉奉治疗,对比两组的临床疗效及不良反应发生情况。结果观察组临床疗效92.7%优于对照组81.8%,P<0.05,差异具有统计学意义。两组不良反应发生率差异不显著,P>0.05,差异不具有统计学意义。结论采用丁苯酞软胶囊联合依达拉奉治疗脑梗塞效果显著,安全性高。
Objective Observation the clinical effect on butylphthalide soft capsules combine with edaravone in treatment of cerebral infarction. Methods Selected 110 cases with cerebral infarction, divided into control group and treatment group randomly, each group had 55 cases. The control group were treated with edaravone treatment, treatment group were treated with butylphthalide soft capsules combined with edaravone in treatment, and the incidence of adverse reaction of contrast the clinical efifcacy of the two groups. Results The clinical curative effect on observation group 92.7%was better than the control group 81.8%, P〈0.05, had difference statistically signiifcance. adverse reaction rate between the two groups, P〉0.05, had no difference statistically significance. Conclusion The butylphthalide soft capsules combined with edaravone in treatment of cerebral infarction has signiifcant effect and high safety.
出处
《中国继续医学教育》
2015年第16期153-153,共1页
China Continuing Medical Education
关键词
丁苯酞软胶囊
依达拉奉
脑梗塞
Butylphthalide soft capsules, Edaravone, Cerebral infarction
